What is the equity of argenx this year?
argenx has equity of 4.1 B USD this year.
argenx Equity 2024
argenx Equity
4.1 B USD
Ticker
ARGX.BR
ISIN
NL0010832176
WKN
A11602
In 2024, argenx's equity was 4.1 B USD, a 45.63% increase from the 2.81 B USD equity in the previous year.
argenx Aktienanalyse
What does argenx do?
Argenx SE is a biopharmaceutical company dedicated to the development of novel therapeutics for the treatment of serious diseases. The company was founded in 2008 and is headquartered in Gent, Belgium. Argenx utilizes an innovative technology platform, the Simple Antibody platform, to develop customized antibodies with high efficacy. Argenx operates in two main business areas: clinical development and licensing. The company aims to produce outstanding therapeutic agents from each of its platform technologies and drug candidates, which can be used as antibody therapies against serious autoimmune diseases or cancer. Argenx's main product is the drug Efgartigimod, a monoclonal antibody developed for the treatment of multiple autoimmune diseases, particularly generalized Myasthenia Gravis (GMG). The drug is currently in clinical development. In recent years, Argenx has made significant progress in the development of new drugs. For example, the company has announced the discovery of new antibodies for the treatment of Myasthenia Gravis, rheumatoid arthritis, and various types of cancer. Licensing these development pipelines opens up new opportunities for Argenx to create additional therapy options for patients with serious illnesses. Argenx has also established partnerships with leading pharmaceutical companies such as Shire and AbbVie to expand its technology platform and drug candidates into new areas of application. The company is currently working on the development of therapies for rare and serious diseases that have no satisfactory treatment options. With the advancement of its innovative technology platform and the expansion of its portfolio of drug candidates, Argenx is on a promising path to play a leading role in the industry. The company is building an extensive network of partnerships and collaborations to accelerate the further development of its technology platform and products, and to achieve further success in the search for new therapeutic applications and areas of application. Looking ahead, Argenx is poised to play a significant role in the biopharmaceutical industry, particularly in the development of personalized therapy options for the treatment of serious diseases where no satisfactory treatment options currently exist. Argenx is proud of its dedicated team of employees who strive every day to realize the company's vision - to help patients cope with serious illnesses through new and innovative therapies. Output: Argenx SE is a biopharmaceutical company dedicated to the development of novel therapeutics for the treatment of serious diseases. argenx ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing argenx's Equity
argenx's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding argenx's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating argenx's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
argenx's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in argenx’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about argenx stock
What was the equity of argenx compared to the previous year?
The equity of argenx has increased/decreased by 45.63% increased compared to the previous year.
What impact does a high equity have on investors of argenx?
A high equity is advantageous for investors of argenx as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of argenx?
A low equity can be a risk for investors of argenx, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of argenx affect the company?
An increase in equity of argenx can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of argenx affect the company?
A reduction in equity of argenx can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of argenx?
Some factors that can affect the equity of argenx include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of argenx so important for investors?
The equity of argenx is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can argenx take to change the equity?
To change equity, argenx can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does argenx pay?
Over the past 12 months, argenx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, argenx is expected to pay a dividend of 0 USD.
What is the dividend yield of argenx?
The current dividend yield of argenx is .
When does argenx pay dividends?
argenx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of argenx?
argenx paid dividends every year for the past 0 years.
What is the dividend of argenx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is argenx located?
argenx is assigned to the 'Health' sector.
Wann musste ich die Aktien von argenx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of argenx from 10/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.
When did argenx pay the last dividend?
The last dividend was paid out on 10/4/2024.
What was the dividend of argenx in the year 2023?
In the year 2023, argenx distributed 0 USD as dividends.
In which currency does argenx pay out the dividend?
The dividends of argenx are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The argenx stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von argenx
Our stock analysis for argenx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of argenx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
